'Historic Deal...': Pfizer CEO praises Trump admin after signing deal on prescription drug prices

Pfizer Inc CEO Albert Bourla said the company secured a three-year grace period from President Donald Trump's promised tariffs on pharmaceuticals in a deal that would lower some of the company's US drug prices. Pfizer will sell some drugs at a 50% average discount on a direct-to-consumer website called TrumpRx, an initiative intended to allow Americans to pay for prescriptions at discounted rates negotiated by the government.
Share this Video
appinstlBnr
Open in App
Success
This article has been saved